Acquiring Company
Navamedic ASA
Acquired Company
dne pharma AS
Description
Navamedic ASA has successfully completed the acquisition of dne pharma AS for a total consideration of up to NOK 225 million. This acquisition includes dne pharma's product portfolio, key employees, and all essential contracts. The deal will enhance Navamedic's presence in the addiction treatment sector, facilitating market access across the Nordics and selected European markets.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed